Trial of Methoxyflurane With Periprostatic Local Anaesthesia to Reduce the Discomfort of TRUS B

PHASE3CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 5, 2019

Study Completion Date

December 30, 2019

Conditions
Cancer
Interventions
DRUG

Methoxyflurane

Participants randomised to the experimental arm will inhale methoxyflurane administered through the Penthrox® inhaler starting approximately one minute before insertion of the rectal probe.

DRUG

Placebo

Participants randomised to the control arm will inhale 0.9% saline administered through the Penthrox® inhaler starting approximately one minute before insertion of the rectal probe.

Trial Locations (7)

2640

Concord Hospital, Concord

Australian Clinical Trials, Wahroonga

Unknown

Casey Hospital, Berwick

The Alfred Hospital, Prahran

Fiona Stanley Hospital, Murdoch

Westmead Hospital, Westmead

Canterbury Urology Research Trust, Christchurch

All Listed Sponsors
collaborator

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

OTHER

lead

University of Sydney

OTHER

NCT02604225 - Trial of Methoxyflurane With Periprostatic Local Anaesthesia to Reduce the Discomfort of TRUS B | Biotech Hunter | Biotech Hunter